nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—CYP3A4—Topotecan—cervical cancer	0.539	1	CbGbCtD
Temozolomide—Metastatic neoplasm—Topotecan—cervical cancer	0.0486	0.105	CcSEcCtD
Temozolomide—Acute leukaemia—Topotecan—cervical cancer	0.0326	0.0707	CcSEcCtD
Temozolomide—Paresis—Topotecan—cervical cancer	0.0255	0.0554	CcSEcCtD
Temozolomide—Myelosuppression—Topotecan—cervical cancer	0.0199	0.0431	CcSEcCtD
Temozolomide—Febrile neutropenia—Topotecan—cervical cancer	0.0155	0.0336	CcSEcCtD
Temozolomide—Interstitial lung disease—Topotecan—cervical cancer	0.0132	0.0285	CcSEcCtD
Temozolomide—Lung disorder—Topotecan—cervical cancer	0.0132	0.0285	CcSEcCtD
Temozolomide—Rigors—Topotecan—cervical cancer	0.0114	0.0247	CcSEcCtD
Temozolomide—Hyperbilirubinaemia—Topotecan—cervical cancer	0.0102	0.0222	CcSEcCtD
Temozolomide—Respiratory failure—Topotecan—cervical cancer	0.00948	0.0206	CcSEcCtD
Temozolomide—Pulmonary embolism—Topotecan—cervical cancer	0.00931	0.0202	CcSEcCtD
Temozolomide—Neuropathy—Topotecan—cervical cancer	0.00874	0.019	CcSEcCtD
Temozolomide—Neoplasm—Topotecan—cervical cancer	0.00842	0.0183	CcSEcCtD
Temozolomide—Ear pain—Topotecan—cervical cancer	0.00792	0.0172	CcSEcCtD
Temozolomide—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.00608	0.0132	CcSEcCtD
Temozolomide—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00596	0.0129	CcSEcCtD
Temozolomide—Pancytopenia—Topotecan—cervical cancer	0.00555	0.012	CcSEcCtD
Temozolomide—Neutropenia—Topotecan—cervical cancer	0.00546	0.0119	CcSEcCtD
Temozolomide—Weight increased—Topotecan—cervical cancer	0.00532	0.0115	CcSEcCtD
Temozolomide—Pneumonia—Topotecan—cervical cancer	0.00524	0.0114	CcSEcCtD
Temozolomide—Infestation NOS—Topotecan—cervical cancer	0.00521	0.0113	CcSEcCtD
Temozolomide—Infestation—Topotecan—cervical cancer	0.00521	0.0113	CcSEcCtD
Temozolomide—Neuropathy peripheral—Topotecan—cervical cancer	0.0051	0.0111	CcSEcCtD
Temozolomide—Stomatitis—Topotecan—cervical cancer	0.00508	0.011	CcSEcCtD
Temozolomide—Hepatobiliary disease—Topotecan—cervical cancer	0.00492	0.0107	CcSEcCtD
Temozolomide—Haemoglobin—Topotecan—cervical cancer	0.0047	0.0102	CcSEcCtD
Temozolomide—Haemorrhage—Topotecan—cervical cancer	0.00467	0.0101	CcSEcCtD
Temozolomide—Hypoaesthesia—Topotecan—cervical cancer	0.00465	0.0101	CcSEcCtD
Temozolomide—Pharyngitis—Topotecan—cervical cancer	0.00464	0.0101	CcSEcCtD
Temozolomide—Angiopathy—Topotecan—cervical cancer	0.00424	0.00921	CcSEcCtD
Temozolomide—Immune system disorder—Topotecan—cervical cancer	0.00422	0.00916	CcSEcCtD
Temozolomide—Mediastinal disorder—Topotecan—cervical cancer	0.00421	0.00914	CcSEcCtD
Temozolomide—Chills—Topotecan—cervical cancer	0.00419	0.0091	CcSEcCtD
Temozolomide—Alopecia—Topotecan—cervical cancer	0.00413	0.00897	CcSEcCtD
Temozolomide—Malnutrition—Topotecan—cervical cancer	0.00407	0.00883	CcSEcCtD
Temozolomide—Back pain—Topotecan—cervical cancer	0.00394	0.00854	CcSEcCtD
Temozolomide—Ill-defined disorder—Topotecan—cervical cancer	0.00378	0.00819	CcSEcCtD
Temozolomide—Anaemia—Topotecan—cervical cancer	0.00376	0.00816	CcSEcCtD
Temozolomide—Angioedema—Topotecan—cervical cancer	0.00372	0.00807	CcSEcCtD
Temozolomide—Malaise—Topotecan—cervical cancer	0.00367	0.00796	CcSEcCtD
Temozolomide—Leukopenia—Topotecan—cervical cancer	0.00364	0.00791	CcSEcCtD
Temozolomide—Cough—Topotecan—cervical cancer	0.00355	0.00771	CcSEcCtD
Temozolomide—Arthralgia—Topotecan—cervical cancer	0.00346	0.00752	CcSEcCtD
Temozolomide—Myalgia—Topotecan—cervical cancer	0.00346	0.00752	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00344	0.00747	CcSEcCtD
Temozolomide—Discomfort—Topotecan—cervical cancer	0.00342	0.00743	CcSEcCtD
Temozolomide—Anaphylactic shock—Topotecan—cervical cancer	0.00332	0.00721	CcSEcCtD
Temozolomide—Infection—Topotecan—cervical cancer	0.0033	0.00716	CcSEcCtD
Temozolomide—Nervous system disorder—Topotecan—cervical cancer	0.00326	0.00707	CcSEcCtD
Temozolomide—Thrombocytopenia—Topotecan—cervical cancer	0.00325	0.00706	CcSEcCtD
Temozolomide—Skin disorder—Topotecan—cervical cancer	0.00323	0.007	CcSEcCtD
Temozolomide—Hyperhidrosis—Topotecan—cervical cancer	0.00321	0.00697	CcSEcCtD
Temozolomide—Anorexia—Topotecan—cervical cancer	0.00317	0.00687	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00303	0.00657	CcSEcCtD
Temozolomide—Paraesthesia—Topotecan—cervical cancer	0.00298	0.00647	CcSEcCtD
Temozolomide—Dyspnoea—Topotecan—cervical cancer	0.00296	0.00643	CcSEcCtD
Temozolomide—Dyspepsia—Topotecan—cervical cancer	0.00292	0.00635	CcSEcCtD
Temozolomide—Decreased appetite—Topotecan—cervical cancer	0.00289	0.00627	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Topotecan—cervical cancer	0.00287	0.00622	CcSEcCtD
Temozolomide—Fatigue—Topotecan—cervical cancer	0.00286	0.00621	CcSEcCtD
Temozolomide—Pain—Topotecan—cervical cancer	0.00284	0.00616	CcSEcCtD
Temozolomide—Constipation—Topotecan—cervical cancer	0.00284	0.00616	CcSEcCtD
Temozolomide—Feeling abnormal—Topotecan—cervical cancer	0.00274	0.00594	CcSEcCtD
Temozolomide—Gastrointestinal pain—Topotecan—cervical cancer	0.00272	0.00589	CcSEcCtD
Temozolomide—Urticaria—Topotecan—cervical cancer	0.00264	0.00573	CcSEcCtD
Temozolomide—Abdominal pain—Topotecan—cervical cancer	0.00263	0.0057	CcSEcCtD
Temozolomide—Body temperature increased—Topotecan—cervical cancer	0.00263	0.0057	CcSEcCtD
Temozolomide—Hypersensitivity—Topotecan—cervical cancer	0.00245	0.00531	CcSEcCtD
Temozolomide—Asthenia—Topotecan—cervical cancer	0.00238	0.00517	CcSEcCtD
Temozolomide—Pruritus—Topotecan—cervical cancer	0.00235	0.0051	CcSEcCtD
Temozolomide—Diarrhoea—Topotecan—cervical cancer	0.00227	0.00493	CcSEcCtD
Temozolomide—Dizziness—Topotecan—cervical cancer	0.0022	0.00477	CcSEcCtD
Temozolomide—Vomiting—Topotecan—cervical cancer	0.00211	0.00458	CcSEcCtD
Temozolomide—Rash—Topotecan—cervical cancer	0.00209	0.00454	CcSEcCtD
Temozolomide—Dermatitis—Topotecan—cervical cancer	0.00209	0.00454	CcSEcCtD
Temozolomide—Headache—Topotecan—cervical cancer	0.00208	0.00452	CcSEcCtD
Temozolomide—Nausea—Topotecan—cervical cancer	0.00197	0.00428	CcSEcCtD
